Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review.

Humans Japan / epidemiology Proton Therapy / adverse effects Heavy Ion Radiotherapy / methods Colorectal Neoplasms / radiotherapy Registries Observational Studies as Topic
carbon ion radiation therapy colorectal cancer particle beam therapy pelvic recurrence proton therapy survival toxicity

Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 10 01 2023
revised: 25 02 2023
medline: 21 6 2023
pubmed: 29 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

The aim of this study was to investigate the efficacy and safety of particle beam therapy (PBT) with proton or carbon ion beam for pelvic recurrence of colorectal cancer (PRCC) by comparing the clinical outcomes of a dataset of prospectively enrolled patients for PBT with those from the literature, which were collected by a systematic review of external X-ray radiotherapy (XRT) and PBT. Patients with PRCC treated at 14 domestic facilities between May 2016 and June 2019 and entered the database for prospective observational follow-up were analyzed. The registry data analyzed included 159 PRCC patients treated with PBT of whom 126 (79%) were treated with carbon ion radiation therapy (CIRT). The 3-year overall survival and local control rate were 81.8 and 76.4%, respectively. Among these PRCC patients, 5.7% had Grade 3 or higher toxicity. Systematic search of PubMed and Cochrane databases published from January 2000 to September 2020 resulted in 409 abstracts for the primary selection. Twelve studies fulfilled the inclusion criteria. With one additional publication, 13 studies were selected for qualitative analysis, including 9 on XRT and 4 on PBT. There were nine XRT studies, which included six on 3D conformal radiotherapy and three on stereotactic body radiation therapy, and four PBT studies included three on CIRT and one on proton therapy. A pilot meta-analysis using literatures with median survival time extractable over a 20-month observation period suggested that PBT, especially CIRT, may be a promising treatment option for PRCC not amenable to curative resection.

Identifiants

DOI: 10.1093/jrr/rrad024 PMID: 37117038 PMC: PMC10278878
pubmed: 37117038
pii: 7146571
doi: 10.1093/jrr/rrad024
pmc: PMC10278878
doi:

Types de publication

Systematic Review Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

i25-i33

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP16lm0103004

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Références

Front Oncol. 2019 Mar 27;9:181
pubmed: 30972294
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
BMC Cancer. 2012 Apr 03;12:137
pubmed: 22472035
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Lancet. 1986 Jun 28;1(8496):1479-82
pubmed: 2425199
J Surg Oncol. 2017 Dec;116(7):932-938
pubmed: 28727901
N Engl J Med. 2006 Sep 14;355(11):1114-23
pubmed: 16971718
J Cancer Res Ther. 2011 Oct-Dec;7(4):408-11
pubmed: 22269400
J Clin Oncol. 2020 May 10;38(14):1569-1579
pubmed: 32160096
Br J Radiol. 2017 Aug;90(1076):20170134
pubmed: 28613934
N Engl J Med. 1997 Apr 3;336(14):980-7
pubmed: 9091798
Radiother Oncol. 2019 Mar;132:236-240
pubmed: 30360998
Surg Today. 2020 Apr;50(4):369-378
pubmed: 31602531
Radiat Oncol J. 2017 Mar;35(1):71-77
pubmed: 28395503
Acta Oncol. 2020 May;59(5):534-540
pubmed: 32056476
Front Oncol. 2019 Jul 31;9:702
pubmed: 31417874
Radiat Oncol. 2020 Aug 28;15(1):209
pubmed: 32859234
Anticancer Res. 2021 Jul;41(7):3589-3595
pubmed: 34230155
Ann Surg Oncol. 2015;22(6):2068-74
pubmed: 25384705
Eur J Surg Oncol. 2001 Jun;27(4):349-53
pubmed: 11417978
Radiat Oncol. 2011 May 20;6:51
pubmed: 21595980
Hepatogastroenterology. 2013 Jan-Feb;60(121):94-8
pubmed: 22784941
J Surg Oncol. 2015 Mar 15;111(4):478-82
pubmed: 25644071
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Br J Radiol. 2012 Mar;85(1011):259-64
pubmed: 21385917
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):93-101
pubmed: 27375166
Int J Clin Oncol. 2020 Jan;25(1):1-42
pubmed: 31203527
Acta Oncol. 2020 Oct;59(10):1218-1223
pubmed: 32476538
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Dis Colon Rectum. 2015 Aug;58(8):753-61
pubmed: 26163954
JCO Glob Oncol. 2020 Feb;6:35-46
pubmed: 32031435
Jpn J Clin Oncol. 2012 Aug;42(8):670-85
pubmed: 22798685
In Vivo. 2019 Jul-Aug;33(4):1363-1368
pubmed: 31280231
World J Gastroenterol. 2006 Apr 28;12(16):2610-4
pubmed: 16688811
Int J Clin Oncol. 2014 Apr;19(2):312-8
pubmed: 23728882
Radiother Oncol. 2019 Jul;136:37-43
pubmed: 31015127
J Med Libr Assoc. 2018 Oct;106(4):420-431
pubmed: 30271283
Ann Surg. 2016 Aug;264(2):323-9
pubmed: 26692078
Anticancer Res. 2015 Mar;35(3):1757-62
pubmed: 25750339
Front Oncol. 2019 Jun 19;9:529
pubmed: 31275858
Int J Cancer. 1998 Aug 21;79(4):365-9
pubmed: 9699528
Ann Surg Oncol. 2010 May;17(5):1343-56
pubmed: 20041351
Jpn J Clin Oncol. 2008 Oct;38(10):695-700
pubmed: 18723850

Auteurs

Shigeyuki Murayama (S)

Division of Proton Therapy, Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8777, Japan.
The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.

Shigeru Yamada (S)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan.

Yuichi Hiroshima (Y)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
Department of Radiation Oncology & Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.

Hirotoshi Takiyama (H)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan.

Hiroshi Taguchi (H)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
Department of Radiation Oncology, Hokkaido University Faculty of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.

Takuya Kimoto (T)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
Department of Radiology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kamigyo-ku, Kyoto 602-0841, Japan.

Makoto Anzai (M)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
Department of Radiology, Osaka Heavy Ion Therapy Center, 3-1-10 Otemae, Chuo-ku, Osaka-city, Osaka 540-0008, Japan.

Yasuhito Hagiwara (Y)

The Japanese Society for Radiation Oncology, Particle Therapy Division, Colorectal Cancer Working Group.
Department of Radiology, Division of Radiation Oncology, Yamagata University Faculty of Medicine, 2-2-2, Iidanishi, Yamagata city, Yamagata 990-9585, Japan.

Kazuaki Yasui (K)

Division of Radiation Oncology, Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8777, Japan.

Keita Mori (K)

Clinical Research Support Center, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8777, Japan.

Soichiro Ishihara (S)

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Hideki Ueno (H)

Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.

Shinichi Shimizu (S)

Department of Carbon Ion Radiotherapy, Graduate School of Medicine, Osaka University, 3-1-10, Otemae, Chuo-ku, Osaka City, Osaka 540-0008, Japan.

Hidefumi Aoyama (H)

Department of Radiation Oncology, Hokkaido University Faculty of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.

Hiroshi Tsuji (H)

QST Hospital, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan.

Hideyuki Sakurai (H)

Department of Radiation Oncology & Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Régions géographiques › Iles › Japon › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Thérapeutique › Radiothérapie › Radiothérapie par ions lourds › Protonthérapie › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Thérapeutique › Radiothérapie › Radiothérapie par ions lourds › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enregistrements › Particle beam therapy for pelvic recurrence of...
Recherchemedicale.com › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Études observationnelles comme sujet › Particle beam therapy for pelvic recurrence of...